Moreover, human non-small cell lung carcinomas with adaptive resistance to MEK inhibitors were highly susceptible to treatment with an additional YAP inhibitor, which suppresses the emergence of resistant cancer cells [159]. The gene discussed is MAP2K7; the disease is cancer.